Case finding for sarcopenia in geriatric inpatients: Performance of bioimpedance analysis in comparison to dual X-ray absorptiometry

BMC Geriatrics

Volumn 16, Issue 1, 2016, Pages

  Reiss, Jens ^a   Iglseder, Bernhard ^a   Kreutzer, Martina ^a   Weilbuchner, Ingrid ^a   Treschnitzer, Wolfgang ^a   Kässmann, Helmut ^a   Pirich, Christian ^a   Reiter, Raphael ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

Bioimpedance analysis; Dual X ray absorptiometry; EWGSOP; Sarcopenia

Indexed keywords

ALGORITHM; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; FEMALE; GAIT; HAND STRENGTH; HOSPITAL PATIENT; HUMAN; IMPEDANCE; MALE; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; PILOT STUDY; PREVALENCE; PROCEDURES; SARCOPENIA; SKELETAL MUSCLE; VERY ELDERLY;

ABSORPTIOMETRY, PHOTON; AGED, 80 AND OVER; ALGORITHMS; ELECTRIC IMPEDANCE; FEMALE; GAIT; HAND STRENGTH; HUMANS; INPATIENTS; MALE; MUSCLE, SKELETAL; PILOT PROJECTS; PREVALENCE; SARCOPENIA;

EID: 84964381110     PISSN: None     EISSN: 14712318     Source Type: Journal    
DOI: 10.1186/s12877-016-0228-z     Document Type: Article

References (24)

1. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127:990S-1.
2. Morley JE, Cruz-Jentoft AJ. Definitions of sarcopenia. In: Cruz-Jentoft AJ, Morley JE, editors. Sarcopenia.Wiley-Blackwell, UK; 2012. p. 8-19.
3. Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci. 2002;57(12):M772-7.
4. Chien MY, Huang TY, Wu YT. Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in Taiwan. J Am Geriatr Soc. 2008;56:1710-5.
5. Patel HP, Syddall HE, Jameson K, Robinson S, Denison H, Roberts HC, et al. Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS). Age Ageing. 2013;42(3):378-84.
6. Rolland Y, Czerwinski S, Abellan Van Kan G, Morley JE, Cesari M, Onder G. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging. 2008;12:433-50.
7. Laurentani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di lorio A, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95:1851-60.
8. Cruz-Jentoft AJ, Landi F, Schneider SM, Zúñiga C, Arai H, Boirie Y, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014;43(6):748-59.
9. Rolland Y, Onder G, Morley JE, Gillette-Guyonet S, Abellan van Kan G, Vellas B. Current and future pharmacologic treatment of sarcopenia. Clin Geriatr Med. 2011;27(3):423-47.
10. Morley JE, Argiles JM, Evans WJ, Bhasin S, Cella D, Deutz NE, et al. Society for Sarcopenia, Cachexia, and Wasting Disease. Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc. 2010;11(6):391-6.
11. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis. Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412-23.
12. Visser M, Schaap L. Measurement of Muscle Mass, Equations and Cut-off Points. In: Cruz-Jentoft AJ, Morley JE, editors. Sarcopenia.Wiley-Blackwell, UK; 2012. p213-216.
13. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gomez JM, et al. Bioelectrical impedance analysis - part I: review of principles and methods. Clin Nutr. 2004;23(5):1226-43.
14. Mijnarends DM, Meijers JM, Halfens RJ, ter Borg S, Luiking YC, Verlaan S, et al. Validity and reliability of tools to measure muscle mass, strength, and physical performance in community-dwelling older people: a systematic review. J Am Med Dir Assoc. 2013;14(3):170-8.
15. Bosaeus I, Wilcox G, Rothenberg E, Strauss BJ. Skeletal muscle mass in hospitalized elderly patients: comparison of measurements by single-frequency BIA and DXA. Clin Nutr. 2014;33(3):426-31.
16. Beaudart C, Reginster JY, Slomian J, Buckinx F, Dardenne N, Quabron A, et al. Estimation of Sarcopenia prevalence using various assessment tools. Exp Gerontol. 2015;61:31-7.
17. Pagotto V, Silveira EA. Applicability and agreement of different diagnostic criteria for sarcopenia estimation in the elderly. Arch Gerontol Geriatr. 2014;59:288-94.
18. Kim J, Heshka S, Gallagher D, Kotler DP, Mayer L, Albu J, et al. Intermuscular adipose tissue-free skeletal muscle mass: estimation by dual-energy X-ray absorptiometry in adults. J Appl Physiol. 2004;97:655-60.
19. Kyle UG, Genton L, Hans D, Pichard C. Validation of a bioelectrical impedance analysis equation to predict appendicular skeletal muscle mass (ASMM). Clin Nutr. 2003;22(6):537-43.
20. Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of muscle mass by bioelectrical impedance analysis. J Appl Physiol. 2000;89:465-71.
21. Baumgartner R, Koehler K, Gallagher D, Romero L, Heymsfield SB, Ross R, et al. Epidemiology of Sarcopenia among Elderly in New Mexico. Am J Epidemiol. 1998;147:755-63.
22. Janssen I, Baumgartner R, Ross R, Rosenberg ICH, Roubenoff R. Skeletal Muscle Cutpoints Asociated with Elevated Physical Disability Risk in Older Men and Women. Am J Epidemiol. 2004;159:413-21.
23. Tengval M, Ellegard L, Malmros V, Bosaeus N, Lissner L, Bosaeus I. Body composition in the elderly: reference values and bioelectrical impedance spectroscopy to predict total body skeletal muscle mass. Clin Nutr. 2009;28(1):52-8.
24. Visser M, Schaap L. Measurement of Muscle Mass, Equations and Cut-off Points. In: Cruz-Jentoft AJ, Morley JE, editors. Sarcopenia.Wiley-Blackwell, UK; 2012. p216-219.